AACT Pre-Meeting Symposium


Standard: $125.00

Products

AACT Pre-Meeting Symposium: Adverse Drug Events - From Public Health to Molecular Mechanisms

Preview Available

AACT Pre-Meeting Symposium: Adverse Drug Events - From Public Health to Molecular Mechanisms

Sep 27, 2013 8:00am ‐ Sep 27, 2013 11:40am

Objectives:

  1. Describe adverse drug events using standard terminology
  2. Incorporate the terminology used in adverse drug effects
  3. State the number of adverse drug effects in the US
  4. Identify medications commonly implicated in adverse drug events
  5. List commonly used tools for causality assessment
  6. Use a causality assessment tool in a case
  7. Describe several systems used to detect adverse drug events
  8. Explain the limitations of these systems
  9. List the essential elements for high quality case reports describing adverse drug events
  10. State how the interpretation of case report is altered when elements are missing
  11. Describe systems for preventing adverse drug events
  12. State the benefits and limitations for each of these systems
  13. Compare the organ specific adverse drug effects on the blood, skin, heart, allergic system, liver,kidney and drug metabolism system
  14. List the clinical manifestations and treatment for adverse events affecting each system

Speaker(s): Speaker(s):

AACT Pre-Meeting Symposium: Adverse Drug Events - From Public Health to Molecular Mechanisms

Preview Available

AACT Pre-Meeting Symposium: Adverse Drug Events - From Public Health to Molecular Mechanisms

Sep 27, 2013 1:00pm ‐ Sep 27, 2013 5:00pm

Objectives:

  1. Describe the pathophysiology and pharmacology of adverse drug events affecting this system; skin necrosis and septra rash in HIV patients
  2. List the clinical manifestations and treatment for adverse events due to Steven's Johnson syndrome, warfarin
  3. List the clinical manifestations and treatment for adverse events due to isoniazid, clavulanic acid and hepatic veno-occlusive disease
  4. List the clinical manifestations and treatment for adverse events due to Type 1, 2, 3 and 4 hypersensitivity reactions
  5. Describe the evidence for and against acetaminophen causing analgesic nephropathy
  6. Report the renal effects of chronic lithium therapy
  7. List the clinical manifestations and treatment for adverse events due to genetic variabilty in P450 and drug interactions

Speaker(s): Speaker(s):
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content